Heidelberg University Hospital in Germany Invests in Fourth Accuray Radiotherapy Device, the Radixact® System, to Improve Cancer Patient Care
MADISON, Wis., June 27, 2024 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) announced today that long-term customer Heidelberg University Hospital in Heidelberg, Germany, has selected the company’s Radixact® System, equipped with its proprietary ClearRT®, Synchrony® and VOLO™ Ultra Optimizer solutions, to help transform their approach to cancer care. The full-featured system is designed to help provide the certainty necessary to effectively and efficiently treat the wide range of cancer cases seen daily in a busy oncology practice. The Radixact System will replace the older generation Accuray TomoTherapy® System.